<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">Malignant disease is widely prevalent and considered to be the major challenges of this century, which concerns the medical community all over the world [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Cancer has sustained cellular proliferative capacity. Although the mechanism of initiation and progression of cancer has been well established, the successful treatment of cancer remains a huge challenge facing the lack of early detection, undefined tumor cell dormancy status, and metastatic properties of malignant tumor [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR3">3</xref>]. The development of anticancer drug resistance, which leads to the failure of most chemotherapeutic anticancer treatments, is significantly restricted the clinical efficacy of the most commonly prescribed anticancer drug [
 <xref ref-type="bibr" rid="CR4">4</xref>]. Consequently, there is an urgent need for the implementation of efficient prevention and treatment strategies to curb cancer deaths. Investigating small molecule antitumor agents, which could decrease drug resistance and reduce unpleasant side effect is more desirable [
 <xref ref-type="bibr" rid="CR5">5</xref>].
</p>
